Andrew McKillop

Andrew is currently head of Pharmaceutical Sciences Small Molecule. This group ensures the successful alignment, collaboration and strategic planning across Analytical R&D, Chemical R&D, Drug Product Design, Drug Product Supply, Data Sciences and Strategic Business Solutions lines, in order to effectively & efficiently deliver the portfolio from candidate nominations to filings. The PSSM team’s focus is on capacity and operational alignment for the Research and Business Unit technical and supply needs. Andrew was previously Vice President Pharmaceutical Sciences QA with responsibility for the Manufacturing (GMP) Quality of the Pfizer R&D Portfolio and Senior Director/Team Leader of the Scientific and Laboratory Services group, Global Quality Operations with responsibility for operations in Collegeville, Groton, Kalamazoo, Parsippany, Sandwich and Singapore. SLS provides expert scientific and analytical support to PGS & Global External Supply Manufacturing sites, and other customers such as WRD and Global Security. Earlier in his career, Andrew was the Quality Operations Lead for the Pharmaceutical Sciences Quality Assurance group in Groton, Connecticut responsible for the quality oversight of API, Drug Product and Packaging/Labeling production in Groton, as well as products manufactured by PGS and external manufacturers for use in clinical trials. Andrew started his career at Pfizer in Analytical R&D in 1996, moving to Ann Arbor in 2002, working on the development and registration of several new products. In 2005 he took on a PhSci team leader role, moving to Groton CT in2006, and led a number of early and late phase projects in development, also working in project alliances with external companies. Andrew holds a BSc in Chemistry, PhD in analytical chemistry and an MBA.